Georgia State, Columbia Researchers Lead Five-Year Study to Advance Treatment for Rare Eye Disease
New funding from the National Institutes of Health will support innovative therapeutic research to preserve sight.
Read the full articleYou might also wanna read
New Research Seeks to Help Transplanted Cells Thrive in Type 1 Diabetes Treatment
Alexander Vlahos has been awarded a five-year, research grant to support pioneering work aimed at improving therapies for T1D.
Life Biosciences Conducts First Gene Therapy Trial to Reverse Cellular Aging in Patient with Glaucoma
For the first time ever, scientists are attempting to reverse cellular aging in a living patient. The target: incurable vision loss. The ris
popularmechanics.com·14d ago
Life Biosciences Doses First Patient in FDA-Approved Gene Therapy Trial for Age-Related Blindness
Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.
gizmodo.com·1mo ago
IRIS: Revolutionizing Eye Disease Detection with Smarter AI
IRIS, a new AI system, revolutionizes ocular disease diagnosis through a novel dataset and advanced algorithms, outperforming larger models.
Columbia Researcher Discovers Rare Genetic Mutation That Provides Universal Antiviral Immunity
Taking inspiration from a rare mutation that makes people impervious to viral diseases, a Columbia researcher is developing a therapy that c
cuimc.columbia.edu·10mo agoMapping of the Developmental Atlas of the Visual System and Research on Embryonic Neurogenesis Phenomena
Conditions : Embryonic Development; Retinal Anomalies; Neural Development Interventions : Other: Tissue collection and multi-omics sequencin
Comments
Sign in to join the conversation.
No comments yet. Be the first.